<script type="text/javascript">
<!--
document.write('<div id="oa_widget"></div>');
document.write('<script type="text/javascript" src="https://www.openaire.eu/index.php?option=com_openaire&view=widget&format=raw&projectId=undefined&type=result"></script>');
-->
</script>

COPY SCRIPT

For further information contact us at helpdesk@openaire.eu

Colchicine and gout

descriptionPublicationkeyboard_double_arrow_right Article , Other literature type 01 Jun 1991 English Publisher:WileyJournal:Arthritis & Rheumatism, volume 34, pages 782-786 (issn: 0004-3591, eissn: 1529-0131,

Authors: Gene V. Ball; Larry W. Moreland;

doi: 10.1002/art.1780340622

pmid: 2053926

Colchicine and gout

- Summary
- Subjects
- Metrics

Abstract

The purpose of this discussion is to examine these two concerns, the efficacy and safety of colchicine, in the context of this controversy. Of the two, there is less solid information bearing on efficacy than on safety

Related Organizations

University of Alabama at Birmingham
United States

Keywords

Clinical Trials as Topic, Gout, Injections, Intravenous, Humans, Colchicine

Impact byBIP!

	citations This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	29
	popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.	Average
	influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	Top 10%
	impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.	Top 10%

Found an issue? Give us feedback

Average

Top 10%

bronze

Beta

SDGs Suggest

3. Good health

Beta

SDGs:

3. Good health,

Related to Research communities

Knowmad Institut